Growth Metrics

Neuronetics (STIM) Asset Writedowns and Impairment (2022 - 2026)

Neuronetics has reported Asset Writedowns and Impairment over the past 5 years, most recently at -$267000.0 for Q1 2026.

  • Quarterly Asset Writedowns and Impairment fell 5440.0% to -$267000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $315000.0 through Mar 2026, down 91.9% year-over-year, with the annual reading at $587000.0 for FY2025, 85.16% down from the prior year.
  • Asset Writedowns and Impairment was -$267000.0 for Q1 2026 at Neuronetics, down from $205000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $2.0 million in Q4 2024 and troughed at -$596000.0 in Q2 2023.
  • The 5-year median for Asset Writedowns and Impairment is $188500.0 (2025), against an average of $532785.7.
  • Year-over-year, Asset Writedowns and Impairment surged 11715.38% in 2023 and then plummeted 5440.0% in 2026.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $13000.0 in 2022, then surged by 11715.38% to $1.5 million in 2023, then soared by 30.79% to $2.0 million in 2024, then tumbled by 89.8% to $205000.0 in 2025, then crashed by 230.24% to -$267000.0 in 2026.
  • Per Business Quant, the three most recent readings for STIM's Asset Writedowns and Impairment are -$267000.0 (Q1 2026), $205000.0 (Q4 2025), and $205000.0 (Q3 2025).